Broadening Eligibility for Lung Cancer Trials Could Have Huge Impact Broadening Eligibility for Lung Cancer Trials Could Have Huge Impact
Adopting expanded inclusion criteria for clinical trials would nearly double the percentage of patients with advanced non-small-cell lung cancer (NSCLC) who are eligible to enroll, according to new research.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Clinical Trials | Hematology | Lung Cancer | Non-Small Cell Lung Cancer